Publications by authors named "Hitt Sharma"

Claim this Profile
Q
Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples.
Vishal Rathod, Sagar Katke, Sumant Patil, Sachin Bhandare, Laxmikant Kadam, Hitt Sharma

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers.
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Inderjit Sharma

Vaccine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL) in infants.
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Inderjit Sharma

NPJ Vaccines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai

Lancet Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Inci Aydin, Marcus May, Fabio Pisano, Nontsikelelo Mpofu-Maetzig, Leander Grode, Hitt Sharma

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India.
Hitt Sharma, Kiran Marthak, Sameer Parekh, Pramod Pujari, Sunil Shewale

Vaccine X· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Hitt Sharma, K Anil, Sameer Parekh, Pramod Pujari, Sunil Shewale

Vaccine X· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin.
Vishal Rathod, Laxmikant Kadam, Manish Gautam, Prabhu Dasu Gumma, Kevin Marke, Hitt Sharma

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.
Alexandra M Blossey, Sina Brückner, Marcus May, Gerald P Parzmair, Hitt Sharma

Clin Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
Hitt J Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai

Expert Rev Vaccines· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale, Inderjit Sharma

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th1-Th2 Seesaw: An Essential Aspect in Type 1 Diabetes.
Shivani Desai, Ramesh Bhonde, Hitt Sharma, Prajakta Kamble, Jagruti Shimpi

Curr Diabetes Rev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy.
Cyrill A Rentsch, Piet Bosshard, Grégoire Mayor, Malte Rieken, Heike Püschel, Hitt Sharma

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Hitt Sharma, K Anil, Sameer Parekh, Pramod Pujari, Sunil Shewale

Vaccine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines For Type 1 Diabetes: Prevention or Reversal?
Shivani Desai, Shubhangi Buchade, Sohan Chitlange, Hitt Sharma, Dhiraj Bhombe

Curr Diabetes Rev· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
Rajeev Sood, Hitt Sharma, Bhuvaneshwari Sharma, Sameer Parekh, Pramod Pujari

Urol Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing surveillance study to assess the safety and tolerability of an Inactivated Poliomyelitis Vaccine in Indian children.
Hitt Sharma, Rajeev Dhere, Sameer Parekh, Sunil Shewale

Hum Vaccin Immunother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years.
Deepak S Phalgune, Rajiv C Yervadekar, Hitt J Sharma, Rajeev M Dhere, Sameer S Parekh

Hum Vaccin Immunother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
Hitt Sharma, Sangeeta Yadav, Sanjay Lalwani, Subhash Kapre, Suresh Jadhav

Vaccine· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants.
Hitt Sharma, Vishwanath Patil, Dharambhushan Sharma, Subhash Kapre, Suresh Jadhav

Vaccine· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
Hitt J Sharma, Vishwanath D Patil, Sanjay K Lalwani, Mamta V Manglani, Latha Ravichandran

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India.
Hitt J Sharma, Vasant S Padbidri, Subhash V Kapre, Suresh S Jadhav, Rajeev M Dhere

J Infect Dev Ctries· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-14 weeks.
Hitt Sharma, Sangita Yadav, Vishwanath Patil, Betty Chacko, Subhash Kapre

Vaccine· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
Hitt J Sharma, Sangita Yadav, Sanjay K Lalwani, Subhash V Kapre, Suresh S Jadhav

Hum Vaccin· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw-HBV-Hib, a liquid pentavalent vaccine in Indian infants.
Hitt Sharma, Sangita Yadav, Sanjay Lalwani, Vijay Gupta, Subhash Kapre

Vaccine· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis